Tempus AI Overview
- Year Founded
-
2015
- Status
-
Public
- Employees
-
3,800
- Stock Symbol
-
TEM
- Investments
-
13
- Share Price
-
$59.61
- (As of Thursday Closing)
Tempus AI General Information
Description
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Contact Information
Website
www.tempus.comCorporate Office
- 600 West Chicago Avenue
- Suite 510
- Chicago, IL 60654
- United States
Corporate Office
- 600 West Chicago Avenue
- Suite 510
- Chicago, IL 60654
- United States
Tempus AI Timeline
Tempus AI Stock Performance
As of 19-Nov-2026, Tempus AI’s stock price is $59.61. Its current market cap is $10.9B with 182M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $59.61 | $63.62 | $40.77 - $89.09 | $10.9B | 182M | 6.93M | -$1.06 |
Tempus AI Financials Summary
As of 30-Sep-2026, Tempus AI has a trailing 12-month revenue of $1.51B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 15,497,626 | 11,081,607 | 5,320,588 | |
| Revenue | 1,509,350 | 1,271,789 | 693,398 | 531,822 |
| EBITDA | (48,496) | (131,135) | (621,490) | (140,929) |
| Net Income | (189,294) | (245,028) | (705,809) | (214,118) |
| Total Assets | 2,451,598 | 2,274,838 | 926,116 | 564,052 |
| Total Debt | 1,431,911 | 1,327,130 | 468,094 | 488,142 |
Tempus AI Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Tempus AI Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Tempus AI Comparisons
Industry
Financing
Details
Tempus AI Competitors (26)
One of Tempus AI’s 26 competitors is HeartFlow, a Formerly VC-backed company based in Mountain View, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| HeartFlow | Formerly VC-backed | Mountain View, CA | ||||
| GenoSpace | Corporate Backed or Acquired | Boston, MA | ||||
| NantHealth | Formerly VC-backed | Lewisville, TX | ||||
| PierianDx | Private Equity-Backed | Creve Coeur, MO | ||||
| Ibex Medical Analytics | Venture Capital-Backed | Tel Aviv, Israel |
Tempus AI Patents
Tempus AI Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260354802-A1 | Detecting low ejection fraction from electrocardiogram data using artificial intelligence | Pending | 20-Jul-2026 | ||
| WO-2026232011-A1 | Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing | Pending | 30-Apr-2025 | ||
| US-20260337665-A1 | Methylation conversion assessment and controls | Pending | 16-Apr-2025 | ||
| EP-4797268-A1 | Systems and methods for characterizing mutations | Pending | 25-Feb-2025 | ||
| US-20260253673-A1 | Systems and methods for characterizing mutations | Pending | 25-Feb-2025 | G16B30/10 |
Tempus AI Signals
Tempus AI Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Tempus AI Investments & Acquisitions (13)
Tempus AI’s most recent deal was a Merger/Acquisition with Personalis for . The deal was made on 20-Jul-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Personalis | 20-Jul-2026 | Merger/Acquisition | Drug Discovery | ||
| OneOme (A Portfolio of Pharmacogenetics Assets) | 24-Nov-2025 | Corporate Asset Purchase | Buildings and Property | ||
| Paige | 22-Aug-2025 | Merger/Acquisition | Decision/Risk Analysis | ||
| Deep 6 AI | 11-Mar-2025 | Merger/Acquisition | Other Healthcare Technology Systems | ||
| Asylia Diagnostics | 18-Feb-2025 | Later Stage VC | Discovery Tools (Healthcare) |
Tempus AI ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Tempus AI Affiliates
Subsidiaries (4)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Paige | New York, NY | 2017 | |
| Deep 6 AI | Pasadena, CA | 2016 | |
| SEngine Precision Medicine | Bothell, WA | 2015 | |
| Ambry Genetics | Aliso Viejo, CA | 1999 |
Tempus AI FAQs
-
When was Tempus AI founded?
Tempus AI was founded in 2015.
-
Where is Tempus AI headquartered?
Tempus AI is headquartered in Chicago, IL.
-
What is the size of Tempus AI?
Tempus AI has 3,800 total employees.
-
What industry is Tempus AI in?
Tempus AI’s primary industry is Decision/Risk Analysis.
-
Is Tempus AI a private or public company?
Tempus AI is a Public company.
-
What is Tempus AI’s stock symbol?
The ticker symbol for Tempus AI is TEM.
-
What is the current stock price of Tempus AI?
As of 19-Nov-2026 the stock price of Tempus AI is $59.61.
-
What is the current market cap of Tempus AI?
The current market capitalization of Tempus AI is $10.9B.
-
What is Tempus AI’s current revenue?
The trailing twelve month revenue for Tempus AI is $1.51B.
-
Who are Tempus AI’s competitors?
HeartFlow, GenoSpace, NantHealth, PierianDx, and Ibex Medical Analytics are some of the 26 competitors of Tempus AI.
-
What is Tempus AI’s annual earnings per share (EPS)?
Tempus AI’s EPS for 12 months was -$1.06.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process